Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03679754
Recruitment Status : Completed
First Posted : September 20, 2018
Last Update Posted : September 22, 2021
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2, 2019
Actual Study Completion Date : January 19, 2021